ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease
Alzheimer s & Dementia Translational Research & Clinical Interventions2023Vol. 9(1), pp. e12377–e12377
Citations Over TimeTop 1% of 2023 papers
Lawrence S. Honig, Jerome Barakos, Shobha Dhadda, Michio Kanekiyo, Larisa Reyderman, Michael C. Irizarry, Lynn D. Kramer, Chad J. Swanson, Marwan Sabbagh
Abstract
Lecanemab can be administered without titration with modest incidence of ARIA.
Related Papers
- → Interleucinas na encefalopatia hipóxico-isquêmica(2003)14 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)